Anavex Life Sciences Corp (AVXL)

[Schmiggins]

I don't get your use of "risk" of one outcome versus another definition there. Rather the idea is simply: a) What are the odds of a placebo taker quitting smoking, versus b) What are the odds of a drugged patent quitting. And, in this case, the odds were 5 times better in the drugged.

In our situation it is what are the odds of a placebo AD patient showing stat. sig. benefit versus a drugged patient showing stat sig improvement in AD measures. I don't remember what that trial's odds outcome was but apparently the odds were much better for improvement on AD measures in our drugged group than in the placebo group.

Pretty straightforward stuff. .... Remember that that Austrian trial investigator in Munich - Grimmer? - said that's the way investigators like he actually approach things amoung themselves as they observe their trials in action. I have a feeling it's an approach that avoids the hanky-panky that statistical cartwheels can result in .... and do result in ....as we see all over the place lately.